Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Musgrove

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Oncogene|September 7, 1995
Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cellsN J Whitaker, T M Bryan, P Bonnefin, et al.
The Journal of Physiology|February 24, 2001
The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycleS M Valenzuela, M Mazzanti, R Tonini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosisR Hui, R D Macmillan, F S Kenny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancerR Hui, A L Cornish, R A McClelland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
Oncogene|October 31, 1997
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancerR Hui, D H Campbell, C S Lee, et al.
Molecular Pharmacology|September 20, 2001
Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicityA J Burgess, S Pavey, R Warrener, et al.
Oncogene|August 1, 1993
Expression and amplification of cyclin genes in human breast cancerM F Buckley, K J Sweeney, J A Hamilton, et al.
British Journal of Cancer|November 2, 2013
Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cellsR A McCloy, E J Shelley, C G Roberts, et al.
Oncogene|March 9, 2011
Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancerC G Roberts, E K A Millar, S A O'Toole, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Oncogene|September 7, 1995
Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cellsN J Whitaker, T M Bryan, P Bonnefin, et al.
The Journal of Physiology|February 24, 2001
The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycleS M Valenzuela, M Mazzanti, R Tonini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosisR Hui, R D Macmillan, F S Kenny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancerR Hui, A L Cornish, R A McClelland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
Oncogene|October 31, 1997
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancerR Hui, D H Campbell, C S Lee, et al.
Molecular Pharmacology|September 20, 2001
Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicityA J Burgess, S Pavey, R Warrener, et al.
Oncogene|August 1, 1993
Expression and amplification of cyclin genes in human breast cancerM F Buckley, K J Sweeney, J A Hamilton, et al.
British Journal of Cancer|November 2, 2013
Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cellsR A McCloy, E J Shelley, C G Roberts, et al.
Oncogene|March 9, 2011
Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancerC G Roberts, E K A Millar, S A O'Toole, et al.
Pageof 7